JNJ Johnson & Johnson Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

JNJ [NYSE]

Johnson & Johnson

Healthcare | Drug Manufacturers - General | USA

statements

Index	DJIA S&P500	P/E	25.91	EPS (ttm)	5.58	Insider Own	0.08%	Shs Outstand	2.63B	Perf Week	-2.67%
Market Cap	375.16B	Forward P/E	15.98	EPS next Y	9.04	Insider Trans	-2.05%	Shs Float	2.63B	Perf Month	-5.07%
Income	14.89B	PEG	5.10	EPS next Q	1.96	Inst Own	70.30%	Short Float	0.40%	Perf Quarter	3.30%
Sales	80.50B	P/S	4.66	EPS this Y	0.50%	Inst Trans	-0.85%	Short Ratio	1.71	Perf Half Y	20.97%
Book/sh	23.92	P/B	6.04	EPS next Y	14.91%	ROA	9.70%	Target Price	165.06	Perf Year	9.80%
Cash/sh	7.37	P/C	19.61	EPS next 5Y	5.08%	ROE	25.10%	52W Range	109.16 - 157.00	Perf YTD	-0.98%
Dividend	4.04	P/FCF	51.53	EPS past 5Y	-0.20%	ROI	17.30%	52W High	-7.95%	Beta	0.69
Dividend %	2.80%	Quick Ratio	1.00	Sales past 5Y	2.00%	Gross Margin	65.80%	52W Low	32.39%	ATR	2.92
Employees	132200	Current Ratio	1.20	Sales Q/Q	-10.80%	Oper. Margin	20.30%	RSI (14)	39.25	Volatility	2.19% 2.00%
Optionable	Yes	Debt/Eq	0.48	EPS Q/Q	-34.70%	Profit Margin	18.90%	Rel Volume	0.82	Prev Close	144.44
Shortable	Yes	LT Debt/Eq	0.40	Earnings	Oct 13 BMO	Payout	66.90%	Avg Volume	6.19M	Price	144.52
Recom	1.90	SMA20	-3.11%	SMA50	-2.98%	SMA200	-0.38%	Volume	2,645,875	Change	0.06%

Apr-28-20

Downgrade

UBS

Buy → Neutral

$163 → $160

Apr-22-20

Upgrade

BofA/Merrill

Neutral → Buy

$150 → $175

Mar-05-20

Initiated

Citigroup

Buy

$163

Dec-19-19

Upgrade

Barclays

Equal Weight → Overweight

$173

Dec-17-19

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$145 → $170

Nov-20-19

Initiated

Cantor Fitzgerald

Overweight

$160

Oct-16-19

Upgrade

Atlantic Equities

Underweight → Neutral

Oct-11-19

Upgrade

Bernstein

Mkt Perform → Outperform

$155

Jul-12-19

Resumed

Credit Suisse

Outperform

$156

May-28-19

Initiated

Goldman

Buy

Jan-23-19

Reiterated

Barclays

Equal Weight

$137 → $135

Jul-12-18

Upgrade

Goldman

Sell → Neutral

Jun-27-18

Initiated

Bernstein

Mkt Perform

$129

Apr-23-18

Reiterated

Citigroup

Neutral

$146 → $134

Apr-18-18

Reiterated

Stifel

Hold

$145 → $135

Jan-24-18

Reiterated

Stifel

Hold

$142 → $145

Jan-12-18

Reiterated

Wells Fargo

Outperform

$155 → $160

Jan-02-18

Downgrade

JP Morgan

Overweight → Neutral

Oct-18-17

Reiterated

Stifel

Hold

$140 → $142

Oct-18-17

Reiterated

RBC Capital Mkts

Outperform

$144 → $147

Sep-24-20 12:14PM	Coronavirus update: Trump suggests he may overrule FDA vaccine approval; airlines ramp up testing Yahoo Finance
11:34AM	Morning Bell With Jim Cramer: Is Johnson & Johnson a Buy? TheStreet.com
10:43AM	Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says Barrons.com
10:19AM	With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table? TheStreet.com
09:58AM	Dow Jones Today, Stocks Rebound Off Opening Lows; Tesla Drags On Nasdaq; Jefferies Financial, Owens & Minor Spike Investor's Business Daily
07:54AM	The Stock Market Is Having a September to Forget Barrons.com
07:53AM	3 Stocks to Buy Ahead of the Next Market Crash Motley Fool
07:52AM	A List of All the Covid-19 Vaccine Candidates That Are Now in Final Trials Barrons.com
07:44AM	Top 3 Dividend Stocks You'll Want to Own Forever Motley Fool
06:36AM	For Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue? Motley Fool
02:21AM	Johnson & Johnson Begins Final Stage Trial of COVID-19 Vaccine; Target Price $170 FX Empire
01:38AM	PRESS DIGEST- New York Times business news - Sept 24 Reuters
Sep-23-20 08:33PM	Trump Says Kentucky Attorney General Is Handling Breonna Taylor Situation Very Well Barrons.com
08:19PM	Trump says Kentucky attorney general is handling Breonna Taylor situation very well and refuses to commit to peaceful transition of power MarketWatch
04:47PM	Dow Falls 500 Points as Fed Warns More Stimulus Needed TheStreet.com
04:26PM	Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial Motley Fool
04:25PM	Johnson & Johnson stock outperforms competitors on strong trading day MarketWatch
04:20PM	Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 Vaccine Investor's Business Daily
03:26PM	Coronavirus Latest: Wednesday, September 23 Yahoo Finance Video
02:41PM	Cramer Reacts To Johnson & Johnson's Coronavirus Vaccine Update: 'Not A Hype Company' Benzinga
02:13PM	Johnson & Johnson CSO on COVID-19 vaccine: We wont have it by October maybe by the end of the year Yahoo Finance Video
01:33PM	Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles MarketWatch
01:29PM	Dow Jones Red Despite Big Nike Rally; Nasdaq Drops As Tech Stocks Sell Off Investor's Business Daily
01:28PM	'Pandemic fatigue is hitting the nation': Expert Yahoo Finance Video
11:58AM	US STOCKS-Wall Street retreats as business activity slows Reuters
11:45AM	Why Vaxart Stock Is Retreating Today Motley Fool
11:39AM	The Dow Is Struggling, and Tesla Stock Slumps Barrons.com
11:06AM	FDA commissioner: It's up to drug makers developing vaccines to seek approval or EUA MarketWatch
10:52AM	Fauci predicts U.S. will know if COVID-19 vaccines are effective by "November or December" MarketWatch
10:51AM	J&J Launches Trial of Single-Dose Covid Vaccine. Results Could Come Quicker Than You Think. Barrons.com
10:45AM	Nike, Johnson & Johnson share gains lead the way, but Dow flat MarketWatch
10:19AM	US STOCKS-S&P 500, Nasdaq retreat as business activity dips Reuters
09:59AM	Dow Jones Today Jumps, Nasdaq Dips As Nike Rallies; J&J Vaccine Enters Phase 3 Investor's Business Daily
09:47AM	Johnson & Johnson Launches Phase 3 Coronavirus Vaccine Trial, Shares Jump TheStreet.com
09:45AM	Nike, Boeing share gains contribute to Dow's 135-point climb MarketWatch
09:33AM	Dow rises over 100 points as stocks continue rebound from selloff MarketWatch
09:18AM	J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers Reuters
08:52AM	Coronavirus update: Johnson & Johnson vaccine enters phase 3 as Fauci heads to Senate Yahoo Finance
08:20AM	Johnson & Johnson Stock Is Jumping, General Mills Is Gaining, and the Dow Is Joining the Party Barrons.com
06:56AM	Johnson & Johnson's stock rallies after Phase 3 trial launched for COVID-19 vaccine candidate MarketWatch
06:45AM	Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate CNW Group
06:45AM	J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers Reuters
Sep-22-20 05:45PM	Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know Zacks
04:25PM	Johnson & Johnson stock underperforms Tuesday when compared to competitors MarketWatch
Sep-21-20 04:27PM	Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail Investor's Business Daily
04:25PM	Johnson & Johnson stock falls Monday, underperforms market MarketWatch
02:04PM	Instead of Going Public, Cancer-Testing Spinoff Grail Is Returning to Illumina Barrons.com
10:42AM	Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain. Barrons.com
09:00AM	Why Legend Biotech Stock Is Sinking Today Motley Fool
Sep-20-20 06:09AM	3 Best Coronavirus Vaccine Stocks to Buy Right Now Motley Fool
Sep-18-20 04:25PM	Johnson & Johnson stock outperforms competitors on strong trading day MarketWatch
04:19PM	First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO Investor's Business Daily
03:57PM	EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.? Reuters
03:12PM	Three-quarters of Americans are worried about the vaccine rush: Pew Yahoo Finance Video
12:50PM	Dow Jones Extends Losses As Apple Drops; Nasdaq Falls Deeper In The Red Investor's Business Daily
11:12AM	EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.? Reuters
10:26AM	Price Over Earnings Overview: Johnson & Johnson Benzinga
09:51AM	Why Novartis Absence From the Covid-19 Vaccine Race Is a Benefit InvestorPlace
09:26AM	Moderna CEO downplays vaccine timeline pressure: 'We don't want the first, we want the best' Yahoo Finance
08:45AM	These 3 Dividend Aristocrats Will Shield You From Another Market Crash Motley Fool
08:04AM	How Much Of Johnson & Johnson (NYSE:JNJ) Do Institutions Own? Simply Wall St.
06:08AM	3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other Motley Fool
05:31AM	20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening InvestorPlace
Sep-17-20 10:06PM	Johnson & Johnson Downplayed Opioid Drugs' Side Effects, New York Unveils Charges Benzinga
05:48PM	EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.? Reuters
05:27PM	New York Files Charges Against Johnson & Johnson Over Opioid Marketing Motley Fool
05:02PM	Economic recovery wont come until we get Americans to feel safe: Ric Edelman Yahoo Finance Video
04:54PM	Infectious Diseases Physician on COVID-19 vaccine outlook: 'Its less about whats the exact date, but making sure its effective' Yahoo Finance Video
04:25PM	Johnson & Johnson stock underperforms Thursday when compared to competitors MarketWatch
03:29PM	FOCUS-Pfizer vaccine trial bets on early win against coronavirus, documents show Reuters
11:21AM	Johnson & Johnson Faces New York State Insurance Fraud Action Linked to Opioid Crisis TheStreet.com
11:06AM	Race for a COVID-19 vaccine continues, here's what you need to know Yahoo Finance Video
Sep-16-20 04:25PM	Johnson & Johnson stock falls Wednesday, still outperforms market MarketWatch
02:04PM	Cos. with a real vaccine history will have their data sets in early 2021: Expert Yahoo Finance Video
06:08AM	3 Steady Stocks to Buy in a Highly Volatile Market Motley Fool
Sep-15-20 05:45PM	Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
03:49PM	Coronavirus update: Trump says vaccine ready within weeks; Pfizer says some patients show side effects Yahoo Finance
12:27PM	US government must rebuild trust in the FDA: top doctor Yahoo Finance
11:58AM	Trump says COVID-19 vaccine will be ready within 'weeks' Yahoo Finance Video
11:44AM	Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator Reuters
10:32AM	Some back out of J&J COVID-19 vaccine trial in Spain after AstraZeneca scare, lead investigator says Reuters
09:46AM	Dow jumps 175 points on gains for shares of Apple Inc., Dow Inc. MarketWatch
Sep-14-20 11:58AM	AstraZeneca resumes COVID-19 vaccine trial Yahoo Finance Video
05:06AM	Johnson & Johnson Kicks Off Phase 2 Covid-19 Vaccine Trial In Spain Report SmarterAnalyst
Sep-13-20 10:38PM	J&J unit to start mid-stage COVID-19 vaccine trials in Spain Reuters
02:43PM	10 Biggest Pharmaceutical Companies in the World in 2020 Insider Monkey
02:35PM	J&J unit to start mid-stage COVID-19 vaccine trials in Spain Reuters
06:08AM	Coronavirus Vaccine Race: 7 Key Things You'll Want to Know Motley Fool
Sep-12-20 06:35AM	3 Dividend Stocks I'd Buy Right Now Motley Fool
Sep-11-20 02:28PM	Coronavirus update: China to begin trials of nasal spray vaccine; Fauci warns on 2nd wave Yahoo Finance
11:59AM	J&J Seeks Label Expansion of Darzalex Faspro for Amyloidosis Zacks
11:51AM	Where COVID-19 vaccines stand following AstraZeneca setback Yahoo Finance Video
10:19AM	China approves COVID-19 nasal spray vaccine testing Yahoo Finance Video
08:35AM	5 Top Dividend Kings to Buy and Hold Forever Motley Fool
Sep-10-20 03:41PM	COVID-19 vaccine doses could arrive in Canada early in 2021 -minister Reuters
12:57PM	Caterpillar, UnitedHealth share losses lead Dow's 133-point drop MarketWatch
12:29PM	5 Health Care Stocks in Gurus' Portfolios GuruFocus.com
11:56AM	Dow's 60-point drop led by losses for shares of Caterpillar, Johnson & Johnson MarketWatch
Sep-09-20 05:45PM	Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
05:44PM	What to Know About Grail, the Cancer-Test Company That Filed to Go Public Barrons.com

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wengel Kathryn E	EVP, Chief GSC Officer	Sep 02	Option Exercise	63.75	16,115	1,027,323	74,535	Sep 04 02:58 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Sep 02	Sale	153.52	16,115	2,473,938	58,420	Sep 04 02:58 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Jul 28	Sale	147.47	29,000	4,276,630	21,682	Jul 28 06:43 PM
JOHNSON & JOHNSON	10% Owner	Jun 30	Buy	17.00	725,000	12,325,000	3,670,516	Jul 02 04:58 PM
PEREZ WILLIAM D	Director	Mar 13	Buy	127.69	500	63,843	16,030	Mar 17 04:24 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Option Exercise	90.44	19,224	1,738,619	75,039	Feb 25 04:23 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Sale	147.96	39,224	5,803,583	35,815	Feb 25 04:23 PM
Ullmann Michael H	Exec VP, General Counsel	Feb 13	Option Exercise	0.00	20,326	0	152,697	Feb 18 05:03 PM
Wolk Joseph J	Exec VP, CFO	Feb 13	Option Exercise	0.00	7,080	0	21,387	Feb 18 05:03 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Feb 13	Option Exercise	0.00	15,809	0	65,532	Feb 18 05:03 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13	Option Exercise	0.00	22,231	0	110,559	Feb 18 05:03 PM
Decker Robert J	Controller, CAO	Feb 13	Option Exercise	0.00	1,499	0	13,946	Feb 18 05:03 PM
Duato Joaquin	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	105,668	0	220,373	Feb 18 05:03 PM
Gorsky Alex	Chairman, CEO	Feb 13	Option Exercise	0.00	107,016	0	496,472	Feb 18 05:03 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 13	Option Exercise	0.00	13,747	0	56,496	Feb 18 05:03 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 13	Option Exercise	0.00	3,692	0	57,259	Feb 18 05:03 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Feb 13	Option Exercise	0.00	11,836	0	61,219	Feb 18 05:03 PM
Stoffels Paulus	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	39,381	0	270,900	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 13	Option Exercise	0.00	16,084	0	115,813	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 03	Option Exercise	0.00	48,312	0	123,450	Feb 04 07:31 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 03	Option Exercise	0.00	38,650	0	58,154	Feb 04 07:31 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Option Exercise	62.62	58,128	3,639,975	107,511	Feb 03 06:28 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Sale	149.39	58,128	8,683,568	49,383	Feb 03 06:28 PM
Joly Hubert	Director	Dec 13	Buy	141.28	5,000	706,399	5,000	Dec 16 04:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Option Exercise	62.62	2,017	126,305	51,736	Dec 16 05:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Sale	141.07	2,017	284,538	49,719	Dec 16 05:40 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience